The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Interventions for structural heart disease

First use of an expandable sheath and transcaval access for transcatheter Edwards SAPIEN 3 aortic valve implantation

EuroIntervention 2015;11:782-784 published online ahead of print May 2015. DOI: 10.4244/EIJY15M05_08

1. Deutsches Herzzentrum München und Technische Universität München, Munich, Germany; 2. Institute for Structural Heart Disease, Division of Cardiology, Henry Ford Health System, Detroit, MI, USA; 3. Deutsches Zentrum für Herz-und Kreislaufforschung (DZHK

Aims: We aimed to describe the first percutaneous transcaval TAVI in Europe using the expandable introducer sheath (eSheath; Edwards Lifesciences, Irvine, CA, USA) for implantation of an

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Thirty-day VARC-2 and performance data of a new self-expanding transcatheter aortic heart valve